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The Myst family of acetyltransferase proteins has been shown to play important role in development and self-renewal, primarily through lysine acetylation
on Histones H3 and H4. In neural development, Myst4 (Morf/KAT6B) has
been found to be critical for self-renewal and for neuron generation in the

Published by Oxford University Press on behalf of the Society for Neuro-Oncology 2014.

Downloaded from https://academic.oup.com/neuro-oncology/article-abstract/16/suppl_5/v78/1053662 by Serials Dept -- College of William and Mary user on 10 December 2018

Abstracts

developing nervous system and during adult neurogenesis. This chromatin modifier exists in a complex with Myst3 (Moz/KAT6A), the bromodomain factor
Brpf1, which acts as a protein scaffold, targeting histone acetyltransferases to
chromatin, as well as Inhibitor of Growth 5 (ING5) and Esa1-associated factor
6 (EAF6). Our laboratories have found alteration of these elements in pediatric
brain cancers, suggesting a pathological role in abnormal neural progenitor
growth. Exon-specific microarrays, DNA methylation studies and functional
perturbation were performed to study the impact on tumor behavior. RNA interference in tumors and neural progenitors led to loss of H3K4acetylation in target
genes and altered expression, including Spondin-1. Conversely, exogenous overexpression of targeting factors, such as Brpf1, enhanced expression of target
genes, assessed by quantitative PCR analysis. Furthermore, expression of
Myst3/4 and Brpf1 positively correlated with tumor malignancy markers in
large patient cohorts, including Ki67, PCNA, and MELK, and with decreased
overall survival. Assessment of direct functional relationships with tumor
markers using ChIP-Seq approaches is currently being pursued to investigate
direct Myst3/4/Brpf1-mediated promoter activity at known and novel target
genes. These studies aim to elucidate the role of an important epigenetic mechanism in neurogenesis, the alteration of which may underlie global chromatin
changes that contribute to tumor growth or initiation. Sustained progenitor
growth may be suppressed by targeted therapies that disrupt these factors.

